Terminal delirium is a common symptom that is frequently underdiagnosed in geriatric patients with cancer at end of life and is a major cause of distress for the patient as well as their family. This article explores the hyperactive and hypoactive delirium subtypes as well as the pathophysiology of terminal delirium and the theory of acetylcholine deficiency and dopamine excess. The causes for terminal delirium underdiagnosis as well as the causes of terminal delirium itself are identified. The use of the Confusion Assessment Method (CAM) is discussed as a means of delirium diagnosis and the Memorial Delirium Assessment scale (MDAS) is presented as a tool to measure its severity. Lastly, nonpharmacologic and pharmacologic treatment measures are reviewed and an algorithm is presented to assist the clinician in the identification and management of terminal delirium.
Macleod ADThe management of terminal delirium. Indian J Palliat Care . 2006;12(1):22-28.
2.
Bruera E., Bush SH, Willey J., et al. Impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers. Cancer.2009;115(9):2004-2012.
3.
Morita T., Tei Y., Tsunoda J., Inoue S., Chihara S.Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients. J Pain Symptom Manage. 2001; 22(6):997-1006.
4.
Cobb JL, Glantz MJ, Nicholas PK, et al. Delirium in patients with cancer at the end of life. Cancer Pract. 2000;8(4):172-177.
5.
Saxena S., Lawley D.Delirium in the elderly: a clinical review. Postgrad Med J.2009;85(1006):405-413.
6.
Pies R.Treating delirium: when the brain goes off track. Psychiatric Times. 2006;23(11). http://www.psychiatrictimes.com/display/article/10168/51921 . Accessed February 15, 2010.
7.
Plonk WM Jr , Arnold RMTerminal care: the last weeks of life. J Palliat Med. 2005;8(5):1042-1054.
8.
Meagher DJ, O’Hanlon D., O’Mahony E., Casey PR, Trzepacz PTRelationship between symptoms and motoric subtype of delirium. J Neuropsychiatry Clin Neurosci. 2000; 12(1):51-56.
9.
Munster BC, Rooij SE, Korevaar JCThe role of genetics in delirium in the elderly patient. Dement Geriatr Cogn Disord.2009; 28(3):187-195.
10.
Brunnhuber K., Nash S., Meier DE, Weissman DE, Woodcock J.Putting Evidence Into Practice: Palliative Care. London, UK: BMJ Publishing Group; 2008:4.
11.
Centeno C., Sanz A., Bruera E.Delirium in advanced cancer patients. Palliat Med. 2004;18(3):184-194.
12.
Gillis AJ, MacDonald B.Unmasked delirium. Can Nurse. 2006; 102(9):18-24.
13.
Lawlor PG, Gagnon B., Mancini IL, et al. Occurrence, causes, and outcomes of delirium in patients with advanced cancer. Arch Intern Med. 2000;160(6):786-794.
14.
Ganzini L.Care of patients with delirium at the end of life. Ann Longterm Care. 2007;15(3):35-40. http://www.annalsolongtermcare.com/article/6904. Accessed January, 2010.
15.
Gagnon P., Charbonneau C., Allard P., Soulard C., Dumont S., Fillion L.Delirium in advanced cancer: a psycho educational intervention for family caregivers. J Palliat Care. 2002;18(4): 253-261.
16.
Voyer P., Richard S., Doucet L., Carmichael P.Detecting delirium and subsyndromal delirium using different diagnostic criteria among demented long-term care residents. J Am Med Dir Assoc . 2009;10(3):181-188.
17.
Inouye S., van Dyck CH, Alessi CA, Balkin S., Siegal A., Horwitz RIClarifying confusion: the confusion assessment method. Ann Internal Med. 1990;113(12):941-948.
McCusker J. , Cole M., Bellavance F., Primeau F.The reliability and validity of a new measure of severity of delirium. Int Psychoger. 1998 ;10(4):421-433.
21.
Clinical Practice Guidelines in Oncology-Palliative Care.National Comprehensive Cancer Network. http://www.nccn.org. Published 2010. Accessed February 13, 2010.
22.
Fine PG, Portenoy RKEstablishing ‘‘best practices’’ for opioid rotation: conclusion of an expert panel. J Pain Symptom Manage.2009;38(3):418-425.
23.
Moryl N., Kogan M., Comfort C., Obbens E.Methadone in the treatment of pain and terminal delirium in advanced cancer patients. Palliat Support Care. 2005;3(4):311-317.
24.
Tabet N., Howard R.Pharmacological treatment for the prevention of delirium: review and current evidence. Int J Geriatr Psychiatry.2009;24(10):1037-1044.
25.
Lonergan E. , Britton AM, Luxenberg J.Antipsychotics for delirium. Cochrane Database of Systematic Reviews. 2007, Issue 2. Art.No.: CD005594. DOI: 10.1002/14651858.cd005594. pub2.
